Latest KFF Health News Stories
Trendy CBD With Its Myriad Of Promises Attracts Attention From Major Consumer Health Companies
While the benefits of most CBD-based products remain to be proven in tests, research estimates the U.S. market will reach almost $24 billion by 2023. News on medical marijuana comes out of Oregon, Louisiana, Missouri and Colorado.
The Harvard and Johns Hopkins doctors were particularly alarmed by the possibility of the poor conditions increasing the spread of infectious diseases.
New Life Breathed Into Pharma’s Efforts To Block California’s Drug Pricing Transparency Law
The legislation would require drugmakers to inform the state and give justification for their price hikes. The judge is allowing the industry to proceed with the argument that the law is unconstitutional because it violates interstate commerce and free speech principles.
Emails obtained by Politico reveal a “singular obsession” from White House senior adviser Stephen Miller when it came to the rule that will allow DHS to bar legal immigrants from obtaining green cards if they receive certain government benefits. The previously undisclosed emails could raise legal questions about whether the public charge rule was rushed to completion. Other news from the
Trump administration looks at disaster aid for Puerto Rico, CDC’s HIV efforts and the FCC’s prioritization of telemedicine.
Health Insurers’ Stocks Are Holding Up Surprisingly Well Despite Choppy Political Waters
The industry is even outpacing others when it comes to profit growth, and UnitedHealth and Anthem, the two largest insurers, each beat Wall Street estimates with their second quarter results. Other health industry news looks at medical device litigation, a lab’s court challenge of a multi-billion dollar Medicare cut, hospices, and more.
Under Intense Congressional Fire, Juul Ramped Up Donations To Lawmakers In First Half Of Year
The new FEC figures show that Democrats, who won control of the House during last year’s elections, received $74,000 from Juul’s PAC between Jan. 1 and June 30 while Republicans received $22,500. In other tobacco news: former FDA chief blasts Juul products, a vast majority of Americans support raising the smoking age, and an annual report looks at how states are working to reduce cancer rates.
For the first time in several years, death rates in urban areas have topped those in rural ones. “It indicates the drug problem is a problem everywhere,” said Holly Hedegaard, epidemiologist at the CDC’s National Center for Health Statistics.
Utah voters in 2018 approved the full expansion with Proposition 3, but lawmakers, citing the potential for runaway costs, repealed the initiative and adopted their own, more restrictive plan. However, the state was rejected from getting the most generous federal funding available because of that decision. Other Medicaid news comes out of Virginia, North Carolina and New Hampshire, as well.
Budget for non-defense programs — ranging from border patrol to veterans’ health care to cancer research — would rise from the current $605 billion this year to $632 billion next year and $634.5 billion the following year. The bill goes to President Donald Trump next, who touted plan as “phenomenal” for veterans.
Keep Your Mitts Off Our Prescription Drugs: Canadians Not Thrilled With Trump’s Importation Plans
Although President Donald Trump’s plan to allow some importation of prescription drugs from Canada is popular in the United States, those in our neighbor to the north are concerned it will cause shortages for them.
Trump Zeroes In On Democrats’ Support For Providing Health Care For Immigrants In Country Illegally
At a rally, President Donald Trump responded to the Democratic debates, focusing on some of the more progressive ideas that emerged. ““They put foreign citizens before American citizens,” Trump claimed. “We’re not going to do that.” Meanwhile, Republican advisers are having similar thoughts. “The idea they’re going to provide illegal immigrants free health care, that’s not going to go down in union households in Michigan,” said Karl Rove, the former top political adviser to President George W. Bush.
In the past couple of years, Democrats have found health care to be a winning issue for them politically. But as the candidates edge toward “Medicare for All” and public option plans, the issue could once again become a weak spot. And outlets take a look at which issues were missing from this week’s debates.
Today’s early morning highlights from the major news organizations.
If You Smoke Pot, Your Anesthesiologist Needs To Know
Colorado is on the front lines in dealing with how marijuana use affects surgery. Lessons learned on operating tables and in recovery rooms have prompted calls for more research on marijuana nationwide.
Infusion Treatments — Needed or Not — Can Deplete Patients’ Wallets
When it comes to physician-administered infusion drugs, doctors sometimes have a financial reason for their choice and patients often aren’t aware of cheaper options.
KHN’s ‘What The Health?’: Deciphering The Democrats’ Health Debate
Health care was a major topic at the Democratic presidential candidate debates in Detroit on Tuesday and Wednesday, but the focus on plan minutiae may have left viewers more confused than edified. Alice Ollstein of Politico, Kimberly Leonard of the Washington Examiner and Caitlin Owens of Axios join KHN’s Julie Rovner to discuss the points made by the candidates plus a series of Trump administration health initiatives on drug prices and hospital shopping.
Proyecto en California combatiría acuerdos que atrasan salida al mercado de genéricos
La FTC ha estimado que los acuerdos de pago por retraso le cuestan a los consumidores y contribuyentes estadounidenses $3.5 mil millones, en costos más altos de medicamentos cada año.
La charla que tienen que tener los adultos mayores con sus médicos antes de una cirugía
Muchas veces los médicos no hablan con sus pacientes y familiares sobre los riesgos potenciales y las complicaciones que se pueden presentar durante o después de una intervención.
Editorial pages focus on health issues raised in the Democratic debates.
Opinion writers weigh in on these public health topics and other health issues.